ADJUVANT PEMBROLIZUMAB FOR RENAL CELL CARCINOMA (KEYNOTE-564): EXPLORATORY ANALYSIS ACROSS UCLA INTEGRATED STAGING SYSTEM RISK GROUPS AND DISEASE STAGE

Bibliographic Details
Title: ADJUVANT PEMBROLIZUMAB FOR RENAL CELL CARCINOMA (KEYNOTE-564): EXPLORATORY ANALYSIS ACROSS UCLA INTEGRATED STAGING SYSTEM RISK GROUPS AND DISEASE STAGE
Authors: Zhang, Tian, Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Symeonides, Stefan N., Hajek, Jaroslav, Chang, Yen-Hwa, Lee, Jae-Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B., Sawrycki, Piotr, Xu, Lei, Imai, Kentaro, Poehlein, Christian, Powles, Thomas
Source: In Urologic Oncology: Seminars and Original Investigations March 2024 42 Supplement:S7-S8
Database: ScienceDirect
More Details
ISSN:10781439
DOI:10.1016/j.urolonc.2024.01.053
Published in:Urologic Oncology: Seminars and Original Investigations
Language:English